http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106924257-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-13 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P1-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4535 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-55 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439 |
| filingDate | 2017-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-11-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106924257-B |
| titleOfInvention | Proton pump inhibitor and the compound of anti-osteoporotic and application thereof |
| abstract | The present invention provides a kind of proton pump inhibitor and compound of anti-osteoporotic and application thereof, which can be used for treating gastric ulcer or duodenal ulcer；Proton pump inhibitor and anti-osteoporotic are combined, synergistic effect is clinically played, overcomes the adverse reaction of proton pump inhibitor；The cocrystallization hydrate to be formed is connected by hydrogen bond, improves the stability of proton pump inhibitor, and clinical application is safer, quickly absorbs quick acting also without enteric dosage form is made into；In addition, also improving the solubility of proton pump inhibitor, its bioavilability is improved, the proton pump inhibitors such as Dexlansoprazole, Vonoprazan fumarate is solved and is difficult to develop into the technical problem of injection because of poorly water-soluble. |
| priorityDate | 2017-03-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 63.